Oxazine derivatives
US9656974B2 · kind B2 · utility
0Cited by
31References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2016 |
| Grant date | May 23, 2017 |
| Priority date | — |
| Expiry date | Feb 11, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides, for example, a compound mentioned below as a medicament for treating or preventing the diseases induced by production, secretion or deposition of amyloid-β proteins.A compound of the formula (I):wherein R1, R2a, R2b, R3, R4a, R4b, ring A and the dashed lines are defined in the specification,its pharmaceutically acceptable salt or a solvate thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.